Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 184 is a human protein encoded by the CCDC184 gene; it consists of 194 amino acids and includes a domain of unknown function (DUF4677)[2]. Its primary molecular function is protein binding. CCDC184 is broadly and highly expressed in the brain, especially in regions such as the hypothalamus, pons, and pituitary gland[2][12]. Single-cell transcriptomics suggest CCDC184 is highly expressed in postmitotic interneurons and correlated with genes for cell-cell adhesion, indicating possible roles in neuronal migration and morphological differentiation, particularly through potential interactions with cadherin family proteins[5]. Predicted post-translational modifications include phosphorylation, SUMOylation, myristoylation, and acetylation[2]. CCDC184 is found only in mammals and is localized to the cytoplasm[2][3]. Despite associations with certain disease states (e.g., breast cancer tissue studies, arrhythmogenic right ventricular cardiomyopathy), it is not considered a validated therapeutic target, and its detailed molecular function remains uncharacterized[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 184 (CCDC184).